POZEN POZN

  1. All
  2. Video Reports
  3. Headlines
    1. Pozen Resubmits PA NDA, PDUFA In Two Months?

      Headlines

      Thu, 3 Jul 2014

      Jason Napodano : On July 1, 2014, Pozen Inc ( POZN ) announced it had resubmitted the ..... and PA325/40 to the U.S. FDA. Pozen noted that the FDA is expected to ..... investors that on April 25, 2014, Pozen announced receipt of a complete response

    2. After Hour Gainers / Losers

      Headlines

      Tue, 1 Jul 2014

      Top gainers, as of 5:15 p.m.: PED +3.1% . POZN +2.8% . RSG +2.3% . POWR +2.0% . SHLM +2.0% . Top losers, as of 5:15 p.m.: CAMP -14.1% . TIME -9.0% . NSAM -4.5% . DXM -3.6% . TRQ -2.9% . Post your comment!

    3. Pozen resubmits NDA

      Headlines

      Tue, 1 Jul 2014

      Pozen ( POZN +2.8% ) resubmits its NDA for PA8140/PA32540 to the FDA. The resubmission was necessary after the company received a CRL

    4. After hours Gainers / Losers

      Headlines

      Fri, 6 Jun 2014

      Top gainers, as of 5:15 p.m.: FDO +5.3% . POZN +3.9% . SPIL +3.7% . CPE +2.5% . MY +2.4% . Top losers, as of 5:15 p.m.: NSR -9.1% . NADL -2.7% . CUR -2.4% . OTC:ENSV -1.7% . ANFI -1.7% . Post your comment!

    5. Orexigen Will Run: Here's Why

      Headlines

      Tue, 27 May 2014

      By MacsJV : Orexigen Therapeutics ( OREX ) will announce on June 10th the FDA's decision on their weight loss drug Contrave . Recent events in the world of biotech trading provide supporting evidence for Orexigen's share price to run higher into their PDUFA. The IBB is an ETF composed of biotech ...

    6. Word Doctoring

      Headlines

      Fri, 21 Jun 2013

      resembling a consensus on best practices for money funds. For example, earlier this week two former fund executives, Robert Pozen and Terry Hamacher, penned an Opinion article in The Wall Street Journal that stated support for the first of the SEC's two

    « Prev1Next »
    Content Partners